The SGC and ULTRA-DD: An Open Source Target Discovery Partnership
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Presentation
- By: SUNDSTRÖM, Michael (Karolinska University Hospital and Karolinska Institutet, Solna, Sweden)
- Co-author(s): Michael Sundström: Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Solna, Sweden
The number of first in class therapies has remained constant for decades, often less than 10 per year. For such new medicines for pioneer targets, the level of attrition in Phase 2 proof-of-concept clinical studies remains the biggest hurdle. This is in large part due to the poor correlation of results from commonly used model systems compared to.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.